Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others

Neuropharmacology

Volumn 54, Issue 1, 2008, Pages 117-128

  Karson, Miranda A ^a   Whittington, Kevin C ^a   Alger, Bradley E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CCK2; Endocannabinoid; GABAB; LY225910; Muscarinic; Neuronal rhythms

Indexed keywords

BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CANNABINOID 1 RECEPTOR; CARBACHOL; CHAPERONE; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; ENDOCANNABINOID; IONOTROPIC RECEPTOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; TETRAGASTRIN; TETRODOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BLOCKING;

ANESTHETICS, LOCAL; ANIMALS; CARBACHOL; CHOLECYSTOKININ; CHOLINERGIC AGONISTS; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENDOCANNABINOIDS; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MODELS, BIOLOGICAL; NEURAL INHIBITION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TETRODOTOXIN;

EID: 37349125528     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.06.023     Document Type: Article

References (62)

1. Alger B.E., Pitler T.A., Wagner J.J., Martin L.A., Morishita W., Kirov S.A., and Lenz R.A. Retrograde signaling in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. Journal of Physiology (London) 496 (1996) 197-209
2. A(slow). Journal of Neuroscience 18 (1998) 1305-1317
3. Baraban S.C., and Tallent M.K. Interneuronal neuropeptides - endogenous regulators of neuronal excitability. Trends in Neurosciences 27 (2004) 135-142
4. Beinfeld M.C., Meyer D.K., Eskay R.L., Jensen R.T., and Brownstein M.J. The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Research 212 (1981) 51-57
5. Blatow M., Rozov A., Katona I., Hormuzdi S.G., Meyer A.H., Whittington M.A., Caputi A., and Monyer H. A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex. Neuron 38 (2003) 805-817
6. Boden P., and Hill R.G. Effects of cholecystokinin and pentagastrin on rat hippocampal neurons maintained in vitro. Neuropeptides 12 (1988) 95-103
7. Bohme G.A., Stutzmann J.-M., and Blanchard J.-C. Excitatory effects of cholecystokinin in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Brain Research 451 (1988) 309-318
8. Buzsaki G. Theta oscillations in the hippocampus. Neuron 33 (2002) 325-340
9. Carlberg M., Gundlach A.L., Mercer L.D., and Beart P.M. Autoradiographic localization of cholecystokinin A and B receptors in rat brain using [125I]d-Tyr25 (Nle28,31)-CCK 25-33S. European Journal of Neuroscience 4 (1992) 563-573
10. Chapman C.A., and Lacaille J.-C. Cholinergic induction of theta-frequency oscillations in hippocampal inhibitory interneurons and pacing of pyramidal cell firing. Journal of Neuroscience 19 (1999) 8637-8645
11. Cobb S.R., and Davies C.H. Cholinergic modulation of hippocampal cells and circuits. Journal of Physiology (London) 562 (2005) 81-88
12. Cobb S.R., Buhl E.H., Halasy K., Paulsen O., and Somogyi P. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378 (1995) 75-78
13. Cobb S.R., Halasy K., Vida I., Nyiri G., Tamas G., Buhl E.H., and Somogyi P. Synaptic effects of identified interneurons innervating both interneurons and pyramidal cells in the rat hippocampus. Neuroscience 79 (1997) 629-648
14. + conductance. Journal of Neurophysiology 74 (1995) 990-1000
15. Deng P.-Y., and Lei S. Bi-directional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats. Journal of Physiology 572 (2006) 425-442
16. Dockray G.J. Immunochemical evidence of cholecystokinin-like peptides in the brain. Nature 274 (1976) 711-713
17. Dodd J., and Kelly J.S. Excitation of CA1 pyramidal neurones of the hippocampus by the tetra- and octapeptide C-terminal fragments of cholecystokinin. Journal of Physiology 295 (1979) 61P-62P
18. Edwards F.A., Konnerth A., and Sakmann B. Quantal analysis of inhibitory synaptic transmission in the dentate gyrus of rat hippocampal slices: a patch-clamp study. Journal of Physiology 430 (1990) 213-249
19. Ferraro L., Beani L., Trist D., Reggiani A., and Bianchi C. Effects of cholecystokinin peptides and GV150013, a selective cholecystokinin B receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices. Journal of Neurochemistry 73 (1999) 1973-1981
20. Fisahn A., Pike F.G., Buhl E.H., and Paulsen O. Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro. Nature 394 (1998) 186-189
21. Fischer Y., Wittner L., Freund T.F., and Gahwiler B.H. Simultaneous activation of gamma and theta network oscillations in rat hippocampal slice cultures. Journal of Physiology (London) 539 (2002) 857-868
22. Fortin D.A., Trettel J., and Levine E.S. Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. Journal of Neurophysiology 92 (2004) 2105-2112
23. Freund T.F. Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends in Neurosciences 26 (2003) 489-495
24. Freund T.F., and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6 (1996) 347-470
25. Fukudome Y., Ohno-Shosaku T., Matsui M., Omori Y., Fukaya M., Tsubokawa H., Taketo M.M., Watanabe M., Manabe T., and Kano M. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signaling. European Journal of Neuroscience 19 (2004) 2682-2692
26. Gillies M.J., Traub R.D., LeBeau F.E.N., Davies C.H., Gloveli T., Buhl E.H., and Whittington M.A. A model of atropine-resistant theta oscillations in rat hippocampal area CA1. Journal of Physiology 543 (2002) 779-793
27. Glickfeld L.L., and Scanziani M. Distinct timing in the activity of cannabinoid-sensitive and cannabinoid- insensitive basket cells. Nature Neuroscience 9 (2006) 807-815
28. Hefft S., and Jonas P. Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nature Neuroscience 8 (2005) 1319-1328
29. Hoffman A.F., and Lupica C.R. Mechanisms of cannabinoid inhibition of GABAA synaptic transmission in the hippocampus. Journal of Neuroscience 20 (2000) 2470-2479
30. Innis R.B., Correa F.M., Uhl G.R., Schneider B., and Snyder S.H. Cholecystokinin octopeptide- like immunoreactivity: histochemical localization in the rat brain. Proceedings of the National Academy of Sciences of the USA 77 (1979) 6917-6921
31. Isaacson J.S., Solis J.M., and Nicoll R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 10 (1993) 165-175
32. 1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. Journal of Neuroscience 19 (1999) 4544-4558
33. Kombian S.B., Ananthalakshmi K.V.V., Parvathy S.S., and Matowe W.C. Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through γ-aminobutyric acid and γ-aminobutyric acid type B receptors. Journal of Neuroscience Research 79 (2005) 412-420
34. Lenz R.A., Wagner J.J., and Alger B.E. N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. Journal of Physiology (London) 512 (1998) 61-73
35. MacVicar B.A., Kerrin J., and Davidson J. Inhibition of synaptic transmission in the hippocampus by cholecystokinin (CCK) and its antagonism by a CCK analog (CCK-27-33). Brain Research 406 (1987) 130-135
36. 1 in distinct neuronal subpopulations in the adult mouse forebrain. European Journal of Neuroscience 11 (1999) 4213-4225
37. Martin L.A., and Alger B.E. Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus. Neuroscience 92 (1999) 61-71
38. Martin L.A., Wei D.-S., and Alger B.E. Heterogeneous susceptibility of GABAA receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus. Journal of Physiology (London) 532 (2001) 685-700
39. Matto V., Harro J., and Allikmets L. The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat. Neuropharmacology 36 (1997) 389-396
40. McMahon L.L., Williams J.H., and Kauer J.A. Functionally distinct groups of interneurons identified during rhythmic carbachol oscillations in hippocampus in vitro. Journal of Neuroscience 18 (1998) 5640-5651
41. McQuiston A.R., and Madison D.V. Muscarinic receptor activity has multiple effects on the resting membrane potentials of CA1 hippocampal interneurons. Journal of Neuroscience 19 (1999) 5693-5702
42. Mercer L.D., Le V.Q., Nunan J., Jones N.M., and Beart P.M. Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies. Neuroscience Letters 293 (2000) 167-170
43. Miller K.K., and Lupica C.R. Morphine-induced excitation of pyramidal neurons is inhibited by cholecystokinin in the CA1 region of the rat hippocampal slice. Journal of Pharmacology and Experimental Therapeutics 268 (1994) 753-761
44. + conductance in hippocampal interneurons. Journal of Neuroscience 17 (1997) 4994-5003
45. Nicoll R.A., and Alger B.E. A simple chamber for recording from submerged brain slices. Journal of Neuroscience Methods 4 (1981) 153-156
46. Palhalmi J., Paulsen O., Freund T.F., and Hajos N. Distinct properties of carbachol- and DHPG- induced network oscillations in hippocampal slices. Neuropharmacology 47 (2004) 381-389
47. Pawelzik H., Hughes D.I., and Thomson A.M. Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus. Journal of Comparative Neurology 443 (2002) 346-367
48. 3H]y-aminobutyric acid release in slices from various brain areas. European Journal of Pharmacology 250 (1993) 423-430
49. Pitler T.A., and Alger B.E. Cholinergic excitation of GABAergic interneurons in the rat hippocampal slice. Journal of Physiology (London) 450 (1992) 127-142
50. Pitler T.A., and Alger B.E. Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. Journal of Neuroscience 12 (1992) 4122-4132
51. Poncer J.-C., McKinney R.A., Gahwiler B.H., and Thompson S.M. Either N- or P-type calcium channels mediate GABA release at distinct hippocampal inhibitory synapses. Neuron 18 (1997) 463-472
52. Rehfeld J.F. Neuronal cholecystokinin: one or multiple transmitters?. Journal of Neurochemistry 44 (1985) 1-10
53. Reich C.G., Karson M.A., Karnup S.V., Jones L., and Alger B.E. Regulation of IPSP theta rhythms by muscarinic receptors and endocannabinoids in hippocampus. Journal of Neurophysiology 94 (2005) 4290-4299
54. Shinohara S., and Kawasaki K. Electrophysiological changes in rat hippocampal pyramidal neurons produced by cholecystokinin octapeptide. Neuroscience 78 (1997) 1005-1016
55. Singh L., Lewis A.S., Field M.J., Hughes J., and Woodruff G.N. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proceedings of the National Academy of Sciences of the USA 88 (1991) 1130-1133
56. Somogyi P., Hodgson A.J., Smith A.D., Nunzi M.G., Gorio A., and Wu J.Y. Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material. Journal of Neuroscience 4 (1984) 2590-2603
57. 1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
58. Varma N., Carlson G.C., Ledent C., and Alger B.E. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. Journal of Neuroscience 21 (2001) RC188(1-5)
59. Whittington M.A., and Traub R.D. Interneuron Diversity series: Inhibitory interneurons and network oscillations in vitro. Trends in Neurosciences 26 (2003) 676-682
60. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410 (2001) 588-592
61. Wilson R.I., Kunos G., and Nicoll R.A. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31 (2001) 453-462
62. Zarbin M.A., Innis R.B., Wamsley J.K., Snyder S.H., and Kuhar M.J. Autoradiographic localization of cholecystokinin receptors in the rodent brain. Journal of Neuroscience 3 (1983) 877-906